Amperozide

Drug Profile

Amperozide

Alternative Names: FG 5606

Latest Information Update: 11 Jan 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmacia Corporation
  • Class Antidepressants; Antipsychotics; Piperazines; Small molecules
  • Mechanism of Action Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Drug abuse; Psychotic disorders

Most Recent Events

  • 11 Jan 1999 Discontinued-Phase-Unspecified for Drug abuse in Sweden (Unspecified route)
  • 11 Jan 1999 Discontinued-Phase-Unspecified for Drug abuse in USA (Unspecified route)
  • 09 Dec 1994 Discontinued-III for Psychotic disorders in Sweden (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top